Missed and dismissed: Why are women diagnosed later than men?

Here's how you can empower female employees to advocate for their health

Missed and dismissed: Why are women diagnosed later than men?
Here's how you can empower female employees to advocate for their health

Women often face barriers when trying to navigate healthcare systems, which influences the quality of healthcare they receive – if, indeed, they receive care at all. 

The kinds of blockers women face can include not feeling listened to by medical professionals, or having their symptoms or pain dismissed, which can lead to delayed diagnosis for serious conditions such as heart attacks and cancer. In fact, a Danish study found that in over 770 different diseases, women are diagnosed later than men due to medical bias.1

Female health conditions such as endometriosis and menopause can also have a huge impact on a woman’s day-to-day life – and therefore career – resulting in more days off sick, worsening productivity, and even leading to career dropout.

By encouraging and supporting women to advocate for their health and navigate the healthcare system effectively, multinationals can boost the health and wellbeing of female employees. Not only will this aid their performance at work, and their career prospects – it can lead to better productivity and business output.

In this month’s Viewpoint, we’ll explore how you can support your female employees.  

Why do women face medical bias?

Image shows woman during a doctor's appointment

Before we dive into what you can do, it’s important to understand the scale of the challenge and why women face medical bias. Women’s health concerns being dismissed or taken less seriously than men’s is a trend that persists across various medical conditions and in different healthcare settings all around the world.

And there are a few reasons why. Women face medical bias because lots of medical research, diagnostic tools and treatments have been designed around men as the default. Until recently, women have been excluded from clinical trials of drugs because of concerns around fertility and the interference with their potential to have children in the future, often referred to as ‘anticipatory motherhood’. Even today, researchers will often leave women out of trials due to the changes that happen to their bodies during the menstrual cycle.2

Since 2007, the US National Institutes of Health has required that women are included in the research that it funds so that it is representative of women as well as men.3 However, women are still not adequately represented in the individual testing phase of trials run by the pharmaceutical industry, with a 2018 study finding that just 29-34% of participants in early-stage US trials were female,4 with the majority of trials still carried out on men and male mice.5  

As a result of being underrepresented in clinical trials, women are more likely to have serious adverse reactions to drugs. MAXIS data from 2021 shows that 75% of adverse medication reaction paid claims were for women, and in 2022 it was 59%.6

Female pain is routinely ignored or dismissed

Historically, female health problems would often be blamed on ‘hysteria’, and the notion continues to this day, with 2021 research by University College London finding that women’s pain is often ‘routinely underestimated’, due to beliefs that women are oversensitive to pain and tend to exaggerate it. This can lead to women to be under-treated for pain, with it being falsely blamed on psychological reasons.7

Nurofen’s 2024 Gender Pain Gap Index Report has shone a light on the disparity between female and male healthcare, revealing that 62% of women feel their complaints of pain have been ignored. The report found that female pain is ignored or dismissed in girls as young as ten, all the way through to retirement age.

The report surveyed medical students about the gender pain gap, revealing that they’re all too aware of it, but don’t feel they are receiving formal teaching about it during their medical degrees.8

MAXIS Chief Health & Wellness Officer, Dr Leena Johns, says: “Women of all ages deal with a huge number of hurdles when it comes to getting the correct medical treatment – and often they don’t receive the treatment that they need at all. This harms them, and in turn, businesses. Delayed diagnosis can lead to more expensive claims, as it often results in more extensive and costly treatments in the long term.

“As a multinational, you can empower your female staff to be able to advocate for themselves when they’re navigating the healthcare system.

“If you can support your female employees by making them aware of how to ask for the correct care and get the answers they deserve, you’ll set them on the path to better health outcomes.”

Dr Leena Johns, Chief Health & Wellness officer at MAXIS GBN
53% of insurers globally say their typical plans don’t cover prescription drugs for obesity

Women often face a delayed or wrong diagnosis

Image shows a woman feeling unwell at work

Let’s look at some of the conditions where women face dismissal or late diagnosis.

Heart conditions: Heart disease is a leading cause of death in women, but it continues to be misdiagnosed, and women are more likely to die from heart attacks than men. Women are 50% more likely than men to receive the wrong diagnosis for a heart attack.9

Female heart attack symptoms present differently in women than in men – while men may exhibit the ‘classic’ symptoms of chest pain and pain along the left arm, women may present with pain between the shoulder blades, nausea or vomiting and shortness of breath or anxiety.

Heart attack symptoms in women often aren’t picked up because medical students are still taught to recognise a heart attack based on the symptoms of the ‘typical’ 70kg man.10 Sex differences are often not spoken about.

A 2018 study of around 3,000 female and male patients at more than 100 US hospitals shows that women are more likely to have their heart disease symptoms dismissed as anxiety or stress, rather than being taken diagnosed as indications of cardiovascular problems.11

Cancer: On average, cancer is diagnosed two-and-a-half years later in women than men.12

MAXIS claims data from 2017-2023 reveals the conditions women were diagnosed with in the year before they were diagnosed with cancer, showing early warning signs of cancer in women that might be missed. These include digestive/abdomen concerns, back and joint pain and pelvic conditions.13 

Graphic from MAXIS data showing the common diagnoses that women receive before getting a cancer diagnosis, including digestive/abdomen concerns, joint/back pain and pelvic conditions.

There are many cancers where women receive a late diagnosis, including:

  • Ovarian cancer: This cancer is often referred to as a ‘silent killer’ because its symptoms are vague and can be missed. Many women report being dismissed by doctors when they express concerns about bloating, pelvic pain or frequent urination. A UK study by Target Ovarian Cancer found that more than a quarter of women with symptoms saw their GP three times or more before they got a referral for tests.14  
  • Breast cancer: Studies have found that women under 40 with breast cancer are frequently dismissed by doctors due to their age, resulting in delays in diagnosis, leading to a later diagnosis of breast cancer in younger women.15
  • Cancers prevalent in both sexes where women often receive a later diagnosis than men, include pancreatic, rectal, lung, bladder, gastric and lymphoma.16,17,18 

Endometriosis: A 2024 study from the University of York found that women with endometriosis (approximately 1 in 10), wait on average 6.6 years for a diagnosis, despite reporting symptoms like pelvic pain, infertility and heavy periods.19 This delay in diagnosis is partially due to the assumption that women’s complaints about menstrual pain are exaggerated or something that should just be put up with.

Adverse effects on women’s lives, careers and your business

These dismissals and delays can have a huge impact on your employees’ lives and careers, which has knock-on effects for the productivity of your business. Symptoms of undiagnosed or badly managed conditions can affect a female employee’s ability to concentrate and manage stress or can even lead to them quitting their jobs.

A Dutch study of 32,000 women found that one in seven had to take time off work due to period pain, with eight out of ten women coming into work despite feeling unwell, leading to presenteeism.20 Presenteeism increases the likelihood of poor performance, errors, mental health conditions, stress, and burnout and it can also cause poor employee retention.

Endometriosis can have detrimental effects on mental health and cause fatigue, leading to more days off sick. In the UK, endometriosis costs the economy £8.2 billion per year in days off work and healthcare costs.21 Data from 52 countries has shown that 41% of women with endometriosis have given up their job or become unemployed due to the condition.22

Meanwhile, menopause can have a hugely disruptive effect on women’s lives and careers. Up to a third of women experience severe side effects, which can include hot flushes, poor concentration, tiredness, poor memory, feeling low/depressed and lowered confidence.23 A poll by the Fawcett Society of 4,000 women in the UK aged between 45 and 55 found that one in ten had quit their job because of menopause symptoms.24

What can you do to support your people?

A good place for you to start when it comes to prioritising female health is with your employee benefits (EB) programme. By helping your female employees with their health, you can build a happier, healthier workforce, and increase retention of your valued female staff – a real win-win for multinationals.

1) Encourage women to advocate for their health

In terms of patient-advocacy, education and empowerment is key. Here are some quick tips you could share with your female employees to help them advocate for their health and get the care they need and deserve.

Before an appointment:

  • Prepare a list of past medical conditions, surgeries, medications and allergies.
  • Write down any symptoms, including changes in sleep, appetite, weight, energy levels, or periods.
  • Write down any questions in advance.

During an appointment:

  • Be assertive and speak up.
  • Ask for clarification on anything that’s hard to understand.
  • Write down notes of any key points that came up during the appointment.
  • Ask about any potential side effects of treatments prescribed.

Advocate for yourself:

  • Bring a friend or family member to provide support.
  • If something feels off physically, don’t be afraid to speak up.
  • Don’t be scared to ask for a second opinion.

For more tips for employees, download our free flyer to distribute to your people.


2) Run an educational campaign in your workplace

Continuing on the theme of education, you can use internal campaigns to raise awareness on female health issues among employees. Consider marking different health awareness days throughout the year (like Women’s Health Month, Endometriosis Awareness Month and Breast Cancer Awareness Month) and talk about the health issues where women are under-diagnosed.

MAXIS clients can download our menopause awareness toolkit, giving you everything you need to run a menopause campaign.

3) Work with leading local insurers

Healthcare starts locally, so it is important to work with leading insurers that have the best range of coverage, understand local challenges and have relationships with top providers and hospitals.  

4) Use your captive to ensure you’re providing equitable benefits

Using a captive to write EB could be a great way to help advocacy. You could consider reinvesting underwriting profits from the captive into global solutions that provide virtual, tailored support for women’s health, fertility and menopause.

5) Engage men as allies

While we’ve talked a lot about women’s health, this is an issue for all. Men can be allies in this space, helping the women in their life advocate for themselves and tackle any unconscious bias they may see.

[1] Westergaard, D., Moseley, P., et al. (February 2019) Population-wide analysis of differences in disease progression patterns in men and women. Nature Communications. https://www.nature.com/articles/s41467-019-08475-9 (Sourced: May 2025)

[2] Jackson, G. The Guardian (November 13, 2019) The female problem: How male bias in medical trials ruined women’s health https://www.theguardian.com/lifeandstyle/2019/nov/13/the-female-problem-male-bias-in-medical-trials (Sourced: May 2025)

[3] Cottingham, M. (May 2022) Gendered Logics of Biomedical Research: Women in U.S. Phase I Clinical Trials, 2022. Social Problems. https://academic.oup.com/socpro/article/69/2/492/5920830 (Sourced: May 2025)

[4] Chen, A., Wright, H, et al. (October 19, 2017) Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015. Journal of Women’s Health https://pubmed.ncbi.nlm.nih.gov/29048983 (Sourced: May 2025)

[5] Fox, M. The Guardian (November 20, 2023) Despite decades of promise, health research still overlooks women https://www.theguardian.com/science/2023/nov/20/women-health-research-jill-biden-white-house (Sourced: May 2025)

[6] Anon. MAXIS GBN (March 5, 2024) How do industry, culture and gender affect your workforce’s health? https://maxis-gbn.com/knowledge-centre/whitepapers/how-do-industry-culture-and-gender-affect-employee-health-insights-from/ (Sourced: May 2025)

[7] Williams, A. The Conversation (April 8, 2021) Women’s pain is routinely underestimated, and gender stereotypes are to blame – new research https://theconversation.com/womens-pain-is-routinely-underestimated-and-gender-stereotypes-are-to-blame-new-research-158599(Sourced: May 2025)

[8] Anon. Nurofen (October 2024) Gender Pain Gap Index Report 2024 https://www.nurofen.co.uk/see-my-pain/ (Sourced: May 2024)

[9] Anon. British Heart Foundation (August 30, 2016) Women are 50% more likely than men to be given incorrect diagnosis following a heart attack (Women have 50 per cent higher chance misdiagnose after heart attack - BHF) Sourced: May 2025

[10] Epker, E. Forbes (August 30, 2023) Stuck in The 70s: Why The ‘Reference Man’ Needs To Be Replaced As The Standard https://www.forbes.com/sites/evaepker/2023/08/30/stuck-in-the-70s-why-the-current-reference-man-needs-to-be-replaced-as-the-standard/ (Sourced: May 2025)

[11] Lichtman, J.H., Leifheit, E.C., et al. (February 20, 2018) Sex Differences in the Presentation and Perception of Symptoms Among Young Patients with Myocardial Infarction: Evidence from the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients) Circulation. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.031650 (Sourced: May 2025) 

[12] Westergaard, D., Moseley, P., et al. (February 2019) Population-wide analysis of differences in disease progression patterns in men and women. Nature Communications. https://www.nature.com/articles/s41467-019-08475-9 (Sourced: May 2025)

[13] Anon. MAXIS GBN (April 30, 2025) Tackling the cancer crisis: practical strategies for employers and insurers – insights from MAXIS data https://maxis-gbn.com/knowledge-centre/whitepapers/cancer/   (Sourced: May 2025)

[14] Anon. Target Ovarian Cancer (March 7, 2023) International Women's Day 2023: making informed decisions about your health. https://targetovariancancer.org.uk/news/international-womens-day-2023-making-informed-decisions-about-your-health (Sourced: May 2025)

[15] Costa, L., Kumar, R., et al. (February 2024) Diagnostic delays in breast cancer among young women: An emphasis on healthcare providers. The Breast. https://www.sciencedirect.com/science/article/pii/S096097762300749X (Sourced: May 2025)  

[16] Azap, R.A., Hyer, J.M., et al. (January 2021) Sex-based differences in time to surgical care among pancreatic cancer patients: A national study of Medicare beneficiaries. Journal of Surgical Oncology. https://pubmed.ncbi.nlm.nih.gov/33084065/ (Sourced: May 2025)

[17] Sarasqueta, C., Zunzunegui, M.V., et al. (August 14, 2020) Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer. BMC Cancer. https://pmc.ncbi.nlm.nih.gov/articles/PMC7427942/ (Sourced: May 2025)

[18] Din, N.U., Ukoumunne, O.C., et al. (May 15, 2015) Age and Gender Variations in Cancer Diagnostic Intervals in 15 Cancers: Analysis of Data from the UK Clinical Practice Research Datalink. PLoS One. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0127717 (Sourced: May 2025)

[19] Fryer, J., Mason-Jones, A.J. et al. (October 17, 2024) Understanding diagnostic delay for endometriosis: A scoping review using the social-ecological framework. Health Care for Women International. https://www.tandfonline.com/doi/full/10.1080/07399332.2024.2413056 (Sourced: May 2025)

[20] Schoep, M., Adang, E.M.M., et al. (June 27, 2019) Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women. BMJ Open https://pubmed.ncbi.nlm.nih.gov/31248919/ (Sourced: May 2025)

[21] Simoens, S., Dunselman, G., et al. (May 27, 2012) The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Human Reproduction. https://pubmed.ncbi.nlm.nih.gov/22422778/ (Sourced: May 2025)

[22] Hummelshoj, L., Prentice, A. et al. (January 2006) Update on Endometriosis: 9th World Congress on Endometriosis, 14–17 September 2005, Maastricht, the Netherlands. DOI Foundation. https://journals.sagepub.com/doi/10.2217/17455057.2.1.53 (Sourced: May 2025)

[23] Anon. British Menopause Society. Menopause in the Workplace. https://www.womens-health-concern.org/help-and-advice/menopause-in-the-workplace/ (Sourced: May 2025)

[24] Anon. The Fawcett Society (May 2, 2022) Menopause and the Workplace. https://www.fawcettsociety.org.uk/menopauseandtheworkplace (Sourced: May 2025)

This document has been prepared by MAXIS GBN S.A.S and is for informational purposes only – it does not constitute advice. MAXIS GBN S.A.S has made every effort to ensure that the information contained in this document has been obtained from reliable sources but cannot guarantee accuracy or completeness. The information contained in this document may be subject to change at any time without notice. Any reliance you place on this information is therefore strictly at your own risk. 

The MAXIS Global Benefits Network (“Network”) is a network of locally licensed MAXIS member insurance companies (“Members”) founded by AXA France Vie, Paris, France (“AXA”) and Metropolitan Life Insurance Company, New York, NY (“MLIC”). MAXIS GBN S.A.S, a Private Limited Company with a share capital of €4,650,000, registered with ORIAS under number 16000513, and with its registered office at 313, Terrasses de l’Arche – 92727 Nanterre Cedex, France, is an insurance and reinsurance intermediary that promotes the Network. MAXIS GBN S.A.S is jointly owned by affiliates of AXA and MLIC and does not issue policies or provide insurance; such activities are carried out by the Members. MAXIS GBN S.A.S operates in the UK through its UK establishment with its registered address at 1st Floor, The Monument Building, 11 Monument Street, London EC3R 8AF, Establishment Number BR018216 and in other European countries on a services basis. MAXIS GBN S.A.S operates in the U.S. through MAXIS Insurance Brokerage Services, Inc., with its registered office located in New York, USA, a New York licensed insurance broker. MLIC is the only Member licensed to transact insurance business in New York. The other Members are not licensed or authorised to do business in New York and the policies and contracts they issue have not been approved by the New York Superintendent of Financial Services, are not protected by the New York state guaranty fund, and are not subject to all of the laws of New York. MAR01620/0625